Summary:
Drug Supply - Active Substance Okrelizumab - Atc L04Ag08 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
21 Mar 2025 Posting Date:
15 Feb 2025 |
Summary:
Drug Supply-Active Substance Human Inhibitor Alpha1-Proteinase-Atc B02Ab02 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
21 Mar 2025 Posting Date:
15 Feb 2025 |
Summary:
Drug Supply - The Active Substance Apalutamid - Atc L02Bb05 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
21 Mar 2025 Posting Date:
15 Feb 2025 |
Summary:
Drug Supply - The Active Substance Enzalutamide - Atc L02Bb04 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
21 Mar 2025 Posting Date:
15 Feb 2025 |
Summary:
Antidiabetic Drugs-Insulins And Combinations Viii. - Toujeo Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
18 Mar 2025 Posting Date:
14 Feb 2025 |
Summary:
Drug Supplies – Active Ingredient Osimertinib – Atc L01Eb04 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
19 Mar 2025 Posting Date:
14 Feb 2025 |
Summary:
Drug Supplies – Active Ingredient Pembrolizumab – Atc L01Ff02 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
17 Mar 2025 Posting Date:
14 Feb 2025 |
Summary:
Drug Supplies – Active Ingredient Upadacitinib – Atc L04Af03 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
19 Mar 2025 Posting Date:
13 Feb 2025 |
Summary:
Drug Supplies – Active Ingredient Mepolizumab – Atc R03Dx09 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
17 Mar 2025 Posting Date:
13 Feb 2025 |
Summary:
Drug Supplies – Active Ingredient Olaparib – Atc L01Xk01 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
19 Mar 2025 Posting Date:
13 Feb 2025 |
Czech Republic human drugs Tenders Contracts and Bids
Find Czech Republic human drugs tenders and government contracts. Search business opportunities for Czech Republic human drugs tenders, Czech Republic human medicine tenders, Czech Republic generic medicine tenders..